Compound ID | 2

Update compound information

FY-901

Class: Aminoglycoside

Spectrum of activity: Gram-positive
Details of activity: MRSA (methicillin resistant Staphylococcus aureus)
Institute where first reported: Changzhou Fangyuan Pharmaceutical, China
Year first mentioned: 2012
Highest developmental phase: Preclinical
Development status: Active
External links:
Citations:
  • https://pdfs.semanticscholar.org/5bff/745df177c7db7dc91a68926b2eb7ce9a10a4.pdf
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790266/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.